Second-line levofloxacin-based quadruple therapy versus bismuth-based quadruple therapy for Helicobacter pylori eradication and long-term changes to the gut microbiota and antibiotic resistome: a multicentre, open-label, randomised controlled trial

Jyh‐Ming Liou, Xiaotao Jiang, Chieh‐Chang Chen, Jiing‐Chyuan Luo, Ming‐Jong Bair, Po‐Yueh Chen, Chu‐Kuang Chou, Yu‐Jen Fang, Mei‐Jyh Chen, Chien-Chuan Chen, Ji‐Yuh Lee, Tsung‐Hua Yang, Chien-Chun Yu, Chia‐Chi Kuo, Min‐Chin Chiu, Chi-Yi Chen, Chia‐Tung Shun, Wen-Hao Hu, Min‐Horn Tsai, Yao‐Chun Hsu, Cheng‐Hao Tseng, Chi‐Yang Chang, Jaw‐Town Lin, Emad El‐Omar, Ming‐Shiang Wu, Chun‐Ying Wu, Yi‐Chia Lee, Ping‐Huei Tseng, Jeng‐Yih Wu, Chi‐Ming Tai, Ching‐Tai Lee, Wen‐Lun Wang